Becton, Dickinson and Co. | أرباح التشغيل



Operating Profit تغيير تاريخ
Abbott USD 1.91B 41M 2024-12
Agilent USD 376M 32M 2025-01
Align Technology USD 144.15M 18.15M 2024-12
Avanos Medical USD -418500000 430.5M 2024-12
Baxter International USD -435000000 590M 2024-12
Becton, Dickinson and Co. USD 453M 195M 2024-12
Bio-Rad Laboratories USD 58.4M 6.07M 2024-12
Boston Scientific USD 675M 58M 2024-12
Cooper Companies USD 182M 16.4M 2025-01
Danaher USD 1.42B 467M 2024-12
Dentsply International USD -509000000 47M 2024-12
Dexcom USD 188.9M 36.9M 2024-12
Edwards Lifesciences USD 312.6M 38M 2024-12
Exact Sciences USD -876351000 836.95M 2024-12
Globus Medical USD 60.27M 12.18M 2024-12
Hologic USD 229.8M 200K 2024-12
Insulet USD 109.3M 21.2M 2024-12
Integra LifeSciences USD 35.23M 43.36M 2024-12
Intuitive Surgical USD 734.9M 157.6M 2024-12
J&J USD 3.89B 549M 2024-12
Masimo USD -359100000 389.2M 2024-12
Medtronic USD 1.65B 51M 2025-01
Patterson Companies USD 45.44M 7.8M 2025-01
Solventum Corp 136M 139M 2024-12
Stryker USD 581M 504M 2024-12
Tandem Diabetes Care USD -582000 25.51M 2024-12
Teleflex USD -110383000 259.69M 2024-12
Terumo JPY 45.78B 2.7B 2024-12
Thermo Fisher Scientific USD 2.02B 178M 2024-12
Zimmer Biomet Holdings USD 389M 109.5M 2024-12



Becton, Dickinson and Co. أرباح التشغيل - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2025.